Low phospholipid-associated cholestasis and cholelithiasis

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue SUPPL.1, 2012, Pages

  Erlinger, Serge ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 3; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; URSODEOXYCHOLIC ACID;

ACUTE PANCREATITIS; ARTICLE; BILE; BILE DUCT STONE; BILE SECRETION; BILIARY COLIC; CHOLANGIOGRAPHY; CHOLANGITIS; CHOLECYSTECTOMY; CHOLELITHIASIS; CHOLESTASIS; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG CHOICE; ECHOGRAPHY; FAMILY HISTORY; GALLSTONE; GENETIC DISORDER; GENOTYPE; HUMAN; JAUNDICE; LOW PHOSPHOLIPID ASSOCIATED CHOLELITHIASIS; LOW PHOSPHOLIPID ASSOCIATED CHOLESTASIS; MEMBRANE DAMAGE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOPHYSIOLOGY;

AGE DISTRIBUTION; CHOLAGOGUES AND CHOLERETICS; CHOLELITHIASIS; CHOLESTASIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENOTYPE; HUMANS; MUTATION; P-GLYCOPROTEINS; PHENOTYPE; PHOSPHOLIPIDS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SYNDROME; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 84868676894     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/S2210-7401(12)70019-0     Document Type: Article

References (12)

1. Rosmorduc O., Hermelin B., Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001, 120:1459-1467.
2. Rosmorduc O., Hermelin B., Boelle P.-Y., Parc R., Taboury J., Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003, 125:452-459.
3. Rosmorduc O., Poupon R. Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene. Orphanet J Rare Dis 2007, 29:29.
4. Wendum D., Barbu V., Rosmorduc O., Arrivé L., Fléjou J.-F., Poupon R. Aspects of liver pathology in adult patients with MDR3/ABCB4 gene mutations. Virchows Arch 2012, 460:291-298.
5. Poupon R., Arrive L., Rosmorduc O. The cholangiographic features of severe forms of ABCB4/MDR3 deficiencyassociated cholangiopathy in adults. Gastroenterol Clin Biol 2010, 34:380-387.
6. Bacq Y. Liver diseases unique to pregnancy: a 2010 update. Clin Res Hepatol Gastroenterol 2011, 35:182-193.
7. Davit-Spraul A., Gonzales E., Baussan C., Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 2009, 4:1.
8. Lammert F., Wang D.Q.-H., Hillebrandt S., Geier A., Fickert P., Trauner M., et al. Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis. Hepatology 2004, 39:117-128.
9. Oude Elferink R.P., Ottenhoff R., van Wijland M., Frijters C.M., van Nieuwkerk C., Groen A.K. Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein. J Lipid Res. 1996, 37:1065-1075.
10. Marschall H.-U., Wagner M., Zollner G., Fickert P., Diczfalusy U., Gumhold J., et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005, 129:476-485.
11. Ikegami T., Matsuzaki Y., Fukushima S., Shoda J., Olivier J.L., Bouscarel B., et al. Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cells. Hepatology 2005, 41:896-905.
12. Chignard N., Poupon R. Targeting farnesoid x receptor in hepatic and biliary inflammatory diseases. Gastroenterology 2009, 137:734-735. discussion 736.